On January 6, it was reported that according to the documents disclosed by the Hong Kong Stock Exchange on January 6, CITIC SEC Asset Management Co., Ltd. increased its Shareholding on January 3 at an average price of HKD 20.8523 per share.$SINOPHARM (01099.HK)$It acquired 0.2396 million Listed in Hong Kong shares, worth approximately HKD 4.9962 million. After the increase, CITIC SEC Asset Management Co., Ltd.'s latest number of shares held is 0.121 billion, and the good stock ratio rose from 8.99% to 9.02%.
This trade involves other related parties: citic sec - Yunfan single asset management plan.
Additional information: The equity is held by citic sec asset management company on behalf of all the asset management plans it manages, disclosing the shares of sinopharm holdings limited - H share equity.
What is equity disclosure?
According to the requirements of the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) must disclose their shareholding interests in listed companies. The Directors and senior executives of listed companies must disclose their share and debenture interests in both the listed company and its affiliated companies.
Why is equity disclosure important?
Equity disclosure enables investors to identify (1) individuals who control or have the ability to control the shareholding of the listed company and (2) individuals who may benefit from transactions involving entities related to the listed company.
